Dramatic response to nivolumab after local radiotherapy in pulmonary pleomorphic carcinoma with rapid progressive post‐surgical recurrence

Pulmonary pleomorphic carcinoma (PPC) is resistant to anticancer drug treatment, outcomes are poor, and no standard therapy has been established. High PD‐L1 expression has been found in PPCs, suggesting the possible efficacy of an immune checkpoint inhibitor (ICI) in cancer immunotherapy; however, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaguchi, Daizo, Ichikawa, Motoshi, Ito, Masao, Okamoto, Sawako, Kimura, Hayata, Watanabe, Kazuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500956/
https://www.ncbi.nlm.nih.gov/pubmed/30860657
http://dx.doi.org/10.1111/1759-7714.13029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500956/
https://www.ncbi.nlm.nih.gov/pubmed/30860657
http://dx.doi.org/10.1111/1759-7714.13029

Ejemplares similares